Hewlett Packard / Agilent
Hewlett Packard / Agilent is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Hewlett Packard / Agilent.
Hewlett Packard / Agilent is a company.
Key people at Hewlett Packard / Agilent.
Key people at Hewlett Packard / Agilent.
Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets, providing precision instruments, software, services, and consumables for laboratory workflows. Originally spun off from Hewlett-Packard (HP) in 1999, it focuses on chromatography, mass spectrometry, spectroscopy, electronic test, and related technologies, serving pharmaceutical R&D labs, food safety agencies, electronics manufacturers, and research institutions.[1][2][4][6] With roots in HP's measurement organization, Agilent solves complex analytical challenges in drug discovery, environmental testing, and semiconductor validation, generating over $8 billion in revenue at launch and evolving through strategic divestitures to emphasize high-value lab automation and genomics tools.[2][3]
Agilent Technologies emerged from Hewlett-Packard's strategic realignment in 1999, when HP spun off its test-and-measurement, chemical analysis, optics, electronic components, and medical products businesses to create a more agile competitor in precision instrumentation. Formed on August 18, 1999, as a tax-free spin-off, it combined HP's Measurement Organization—dating back to acquisitions like F&M Scientific in 1965 for gas chromatographs—into a standalone entity led by Ned Barnholt as founding president and CEO.[2][3][4][6] The spin-off culminated in a record-breaking $2.1 billion IPO on November 18, 1999 (NYSE: A), the largest in Silicon Valley history at the time, with Agilent starting at 43,000 employees and $8 billion revenue; HP fully divested shares to its shareholders on June 2, 2000, making Agilent independent.[1][3][5][6] Early traction included expansions in chromatography and mass spectrometry amid telecom demand, though economic downturns led to 18,500 layoffs by 2003.[4]
Agilent rides the wave of advancing life sciences and diagnostics, fueled by genomics, personalized medicine, and lab automation trends that demand precise, high-throughput analysis amid rising R&D in pharma and biotech. The 1999 spin-off timing capitalized on HP's need to counter nimble rivals in a dot-com era, allowing Agilent to pivot from broad electronics to specialized instruments as telecom booms faded post-2001.[2][3][4] Market forces like regulatory pressures for food/environmental safety and semiconductor complexity favor its tools, influencing ecosystems by enabling faster drug development and quality control for giants in electronics and healthcare.[1][2] Later, its test-and-measurement lineage spun further into Keysight Technologies (2014), fragmenting HP's original empire while Agilent dominates chemical analysis.[3]
Agilent's trajectory points to sustained growth in precision diagnostics and sustainable lab tech, with trends like AI-driven analytics and green chemistry shaping expansions—exemplified by CEO Mike McMullen's (elected 2010s) push into transformative GC systems. Expect deeper integration with biotech workflows and potential M&A in emerging markets like China via joint ventures. Its influence will evolve from HP's garage innovation to a linchpin in global R&D, powering the next era of scientific breakthroughs much like its 1999 birth unleashed agility from legacy constraints.[8]